 | • レポートコード：QYR2104Z1618 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、新型コロナウイルス感染症診断検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（核酸検査、抗体検査）、用途別市場規模（病院、科学研究）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・新型コロナウイルス感染症診断検査の市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症診断検査の種類別市場規模（核酸検査、抗体検査） ・新型コロナウイルス感染症診断検査の用途別市場規模（病院、科学研究） ・新型コロナウイルス感染症診断検査の北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症診断検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症診断検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症診断検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症診断検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Cellex、Abbott、Roche、BioMedomics、BD、Henry Schein、Safecare Bio-Tech、Mayo Clinic Laboratories、Chembio Diagnostics、Mount Sinai Laboratory、Ortho Clinical Diagnostics、Zhejiang Orient Gene Biotech、Innovita Biological Technology、Guangzhou Wondfo Biotech、Guangdong Hecin-Scientific、Dynamiker Biotechnology (Tianjin)、ADVAITE） ・結論 |
COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
Market Analysis and Insights: Global COVID-19 Diagnostic Testing Market
The global COVID-19 Diagnostic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global COVID-19 Diagnostic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global COVID-19 Diagnostic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global COVID-19 Diagnostic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global COVID-19 Diagnostic Testing market.
Global COVID-19 Diagnostic Testing Scope and Market Size
COVID-19 Diagnostic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Nucleic Acid Testing
Antibody Testing
Segment by Application
Hospitals
Scientific Research
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nucleic Acid Testing
1.2.3 Antibody Testing
1.3 Market by Application
1.3.1 Global COVID-19 Diagnostic Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 Diagnostic Testing Market Perspective (2016-2027)
2.2 COVID-19 Diagnostic Testing Growth Trends by Regions
2.2.1 COVID-19 Diagnostic Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 COVID-19 Diagnostic Testing Historic Market Share by Regions (2016-2021)
2.2.3 COVID-19 Diagnostic Testing Forecasted Market Size by Regions (2022-2027)
2.3 COVID-19 Diagnostic Testing Industry Dynamic
2.3.1 COVID-19 Diagnostic Testing Market Trends
2.3.2 COVID-19 Diagnostic Testing Market Drivers
2.3.3 COVID-19 Diagnostic Testing Market Challenges
2.3.4 COVID-19 Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top COVID-19 Diagnostic Testing Players by Revenue
3.1.1 Global Top COVID-19 Diagnostic Testing Players by Revenue (2016-2021)
3.1.2 Global COVID-19 Diagnostic Testing Revenue Market Share by Players (2016-2021)
3.2 Global COVID-19 Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Diagnostic Testing Revenue
3.4 Global COVID-19 Diagnostic Testing Market Concentration Ratio
3.4.1 Global COVID-19 Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Diagnostic Testing Revenue in 2020
3.5 COVID-19 Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players COVID-19 Diagnostic Testing Product Solution and Service
3.7 Date of Enter into COVID-19 Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Diagnostic Testing Breakdown Data by Type
4.1 Global COVID-19 Diagnostic Testing Historic Market Size by Type (2016-2021)
4.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Type (2022-2027)
5 COVID-19 Diagnostic Testing Breakdown Data by Application
5.1 Global COVID-19 Diagnostic Testing Historic Market Size by Application (2016-2021)
5.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America COVID-19 Diagnostic Testing Market Size (2016-2027)
6.2 North America COVID-19 Diagnostic Testing Market Size by Type
6.2.1 North America COVID-19 Diagnostic Testing Market Size by Type (2016-2021)
6.2.2 North America COVID-19 Diagnostic Testing Market Size by Type (2022-2027)
6.2.3 North America COVID-19 Diagnostic Testing Market Size by Type (2016-2027)
6.3 North America COVID-19 Diagnostic Testing Market Size by Application
6.3.1 North America COVID-19 Diagnostic Testing Market Size by Application (2016-2021)
6.3.2 North America COVID-19 Diagnostic Testing Market Size by Application (2022-2027)
6.3.3 North America COVID-19 Diagnostic Testing Market Size by Application (2016-2027)
6.4 North America COVID-19 Diagnostic Testing Market Size by Country
6.4.1 North America COVID-19 Diagnostic Testing Market Size by Country (2016-2021)
6.4.2 North America COVID-19 Diagnostic Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe COVID-19 Diagnostic Testing Market Size (2016-2027)
7.2 Europe COVID-19 Diagnostic Testing Market Size by Type
7.2.1 Europe COVID-19 Diagnostic Testing Market Size by Type (2016-2021)
7.2.2 Europe COVID-19 Diagnostic Testing Market Size by Type (2022-2027)
7.2.3 Europe COVID-19 Diagnostic Testing Market Size by Type (2016-2027)
7.3 Europe COVID-19 Diagnostic Testing Market Size by Application
7.3.1 Europe COVID-19 Diagnostic Testing Market Size by Application (2016-2021)
7.3.2 Europe COVID-19 Diagnostic Testing Market Size by Application (2022-2027)
7.3.3 Europe COVID-19 Diagnostic Testing Market Size by Application (2016-2027)
7.4 Europe COVID-19 Diagnostic Testing Market Size by Country
7.4.1 Europe COVID-19 Diagnostic Testing Market Size by Country (2016-2021)
7.4.2 Europe COVID-19 Diagnostic Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific COVID-19 Diagnostic Testing Market Size (2016-2027)
8.2 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Type
8.2.1 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Application
8.3.1 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Region
8.4.1 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America COVID-19 Diagnostic Testing Market Size (2016-2027)
9.2 Latin America COVID-19 Diagnostic Testing Market Size by Type
9.2.1 Latin America COVID-19 Diagnostic Testing Market Size by Type (2016-2021)
9.2.2 Latin America COVID-19 Diagnostic Testing Market Size by Type (2022-2027)
9.2.3 Latin America COVID-19 Diagnostic Testing Market Size by Type (2016-2027)
9.3 Latin America COVID-19 Diagnostic Testing Market Size by Application
9.3.1 Latin America COVID-19 Diagnostic Testing Market Size by Application (2016-2021)
9.3.2 Latin America COVID-19 Diagnostic Testing Market Size by Application (2022-2027)
9.3.3 Latin America COVID-19 Diagnostic Testing Market Size by Application (2016-2027)
9.4 Latin America COVID-19 Diagnostic Testing Market Size by Country
9.4.1 Latin America COVID-19 Diagnostic Testing Market Size by Country (2016-2021)
9.4.2 Latin America COVID-19 Diagnostic Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa COVID-19 Diagnostic Testing Market Size (2016-2027)
10.2 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Type
10.2.1 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Application
10.3.1 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Country
10.4.1 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Cellex
11.1.1 Cellex Company Details
11.1.2 Cellex Business Overview
11.1.3 Cellex COVID-19 Diagnostic Testing Introduction
11.1.4 Cellex Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.1.5 Cellex Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott COVID-19 Diagnostic Testing Introduction
11.2.4 Abbott Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche COVID-19 Diagnostic Testing Introduction
11.3.4 Roche Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.3.5 Roche Recent Development
11.4 BioMedomics
11.4.1 BioMedomics Company Details
11.4.2 BioMedomics Business Overview
11.4.3 BioMedomics COVID-19 Diagnostic Testing Introduction
11.4.4 BioMedomics Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.4.5 BioMedomics Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD COVID-19 Diagnostic Testing Introduction
11.5.4 BD Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.5.5 BD Recent Development
11.6 Henry Schein
11.6.1 Henry Schein Company Details
11.6.2 Henry Schein Business Overview
11.6.3 Henry Schein COVID-19 Diagnostic Testing Introduction
11.6.4 Henry Schein Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.6.5 Henry Schein Recent Development
11.7 Safecare Bio-Tech
11.7.1 Safecare Bio-Tech Company Details
11.7.2 Safecare Bio-Tech Business Overview
11.7.3 Safecare Bio-Tech COVID-19 Diagnostic Testing Introduction
11.7.4 Safecare Bio-Tech Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.7.5 Safecare Bio-Tech Recent Development
11.8 Mayo Clinic Laboratories
11.8.1 Mayo Clinic Laboratories Company Details
11.8.2 Mayo Clinic Laboratories Business Overview
11.8.3 Mayo Clinic Laboratories COVID-19 Diagnostic Testing Introduction
11.8.4 Mayo Clinic Laboratories Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.8.5 Mayo Clinic Laboratories Recent Development
11.9 Chembio Diagnostics
11.9.1 Chembio Diagnostics Company Details
11.9.2 Chembio Diagnostics Business Overview
11.9.3 Chembio Diagnostics COVID-19 Diagnostic Testing Introduction
11.9.4 Chembio Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.9.5 Chembio Diagnostics Recent Development
11.10 Mount Sinai Laboratory
11.10.1 Mount Sinai Laboratory Company Details
11.10.2 Mount Sinai Laboratory Business Overview
11.10.3 Mount Sinai Laboratory COVID-19 Diagnostic Testing Introduction
11.10.4 Mount Sinai Laboratory Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.10.5 Mount Sinai Laboratory Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Details
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 Zhejiang Orient Gene Biotech
11.12.1 Zhejiang Orient Gene Biotech Company Details
11.12.2 Zhejiang Orient Gene Biotech Business Overview
11.12.3 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Introduction
11.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.12.5 Zhejiang Orient Gene Biotech Recent Development
11.13 Innovita Biological Technology
11.13.1 Innovita Biological Technology Company Details
11.13.2 Innovita Biological Technology Business Overview
11.13.3 Innovita Biological Technology COVID-19 Diagnostic Testing Introduction
11.13.4 Innovita Biological Technology Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.13.5 Innovita Biological Technology Recent Development
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Details
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Introduction
11.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.14.5 Guangzhou Wondfo Biotech Recent Development
11.15 Guangdong Hecin-Scientific
11.15.1 Guangdong Hecin-Scientific Company Details
11.15.2 Guangdong Hecin-Scientific Business Overview
11.15.3 Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Introduction
11.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.15.5 Guangdong Hecin-Scientific Recent Development
11.16 Dynamiker Biotechnology (Tianjin)
11.16.1 Dynamiker Biotechnology (Tianjin) Company Details
11.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
11.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Introduction
11.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
11.17 ADVAITE
11.17.1 ADVAITE Company Details
11.17.2 ADVAITE Business Overview
11.17.3 ADVAITE COVID-19 Diagnostic Testing Introduction
11.17.4 ADVAITE Revenue in COVID-19 Diagnostic Testing Business (2016-2021)
11.17.5 ADVAITE Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nucleic Acid Testing
Table 3. Key Players of Antibody Testing
Table 4. Global COVID-19 Diagnostic Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global COVID-19 Diagnostic Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global COVID-19 Diagnostic Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global COVID-19 Diagnostic Testing Market Share by Regions (2016-2021)
Table 8. Global COVID-19 Diagnostic Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global COVID-19 Diagnostic Testing Market Share by Regions (2022-2027)
Table 10. COVID-19 Diagnostic Testing Market Trends
Table 11. COVID-19 Diagnostic Testing Market Drivers
Table 12. COVID-19 Diagnostic Testing Market Challenges
Table 13. COVID-19 Diagnostic Testing Market Restraints
Table 14. Global COVID-19 Diagnostic Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global COVID-19 Diagnostic Testing Market Share by Players (2016-2021)
Table 16. Global Top COVID-19 Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COVID-19 Diagnostic Testing as of 2020)
Table 17. Ranking of Global Top COVID-19 Diagnostic Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by COVID-19 Diagnostic Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players COVID-19 Diagnostic Testing Product Solution and Service
Table 21. Date of Enter into COVID-19 Diagnostic Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global COVID-19 Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global COVID-19 Diagnostic Testing Revenue Market Share by Type (2016-2021)
Table 25. Global COVID-19 Diagnostic Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global COVID-19 Diagnostic Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global COVID-19 Diagnostic Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global COVID-19 Diagnostic Testing Revenue Market Share by Application (2016-2021)
Table 29. Global COVID-19 Diagnostic Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global COVID-19 Diagnostic Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America COVID-19 Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America COVID-19 Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America COVID-19 Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America COVID-19 Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America COVID-19 Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America COVID-19 Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe COVID-19 Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe COVID-19 Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe COVID-19 Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe COVID-19 Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe COVID-19 Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe COVID-19 Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific COVID-19 Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific COVID-19 Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific COVID-19 Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific COVID-19 Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific COVID-19 Diagnostic Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific COVID-19 Diagnostic Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America COVID-19 Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America COVID-19 Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America COVID-19 Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America COVID-19 Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America COVID-19 Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America COVID-19 Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa COVID-19 Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa COVID-19 Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa COVID-19 Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa COVID-19 Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa COVID-19 Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa COVID-19 Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Cellex Company Details
Table 62. Cellex Business Overview
Table 63. Cellex COVID-19 Diagnostic Testing Product
Table 64. Cellex Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 65. Cellex Recent Development
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott COVID-19 Diagnostic Testing Product
Table 69. Abbott Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche COVID-19 Diagnostic Testing Product
Table 74. Roche Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 75. Roche Recent Development
Table 76. BioMedomics Company Details
Table 77. BioMedomics Business Overview
Table 78. BioMedomics COVID-19 Diagnostic Testing Product
Table 79. BioMedomics Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 80. BioMedomics Recent Development
Table 81. BD Company Details
Table 82. BD Business Overview
Table 83. BD COVID-19 Diagnostic Testing Product
Table 84. BD Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 85. BD Recent Development
Table 86. Henry Schein Company Details
Table 87. Henry Schein Business Overview
Table 88. Henry Schein COVID-19 Diagnostic Testing Product
Table 89. Henry Schein Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 90. Henry Schein Recent Development
Table 91. Safecare Bio-Tech Company Details
Table 92. Safecare Bio-Tech Business Overview
Table 93. Safecare Bio-Tech COVID-19 Diagnostic Testing Product
Table 94. Safecare Bio-Tech Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 95. Safecare Bio-Tech Recent Development
Table 96. Mayo Clinic Laboratories Company Details
Table 97. Mayo Clinic Laboratories Business Overview
Table 98. Mayo Clinic Laboratories Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 99. Mayo Clinic Laboratories Recent Development
Table 100. Chembio Diagnostics Company Details
Table 101. Chembio Diagnostics Business Overview
Table 102. Chembio Diagnostics COVID-19 Diagnostic Testing Product
Table 103. Chembio Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 104. Chembio Diagnostics Recent Development
Table 105. Mount Sinai Laboratory Company Details
Table 106. Mount Sinai Laboratory Business Overview
Table 107. Mount Sinai Laboratory COVID-19 Diagnostic Testing Product
Table 108. Mount Sinai Laboratory Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 109. Mount Sinai Laboratory Recent Development
Table 110. Ortho Clinical Diagnostics Company Details
Table 111. Ortho Clinical Diagnostics Business Overview
Table 112. Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Product
Table 113. Ortho Clinical Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 114. Ortho Clinical Diagnostics Recent Development
Table 115. Zhejiang Orient Gene Biotech Company Details
Table 116. Zhejiang Orient Gene Biotech Business Overview
Table 117. Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Product
Table 118. Zhejiang Orient Gene Biotech Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 119. Zhejiang Orient Gene Biotech Recent Development
Table 120. Innovita Biological Technology Company Details
Table 121. Innovita Biological Technology Business Overview
Table 122. Innovita Biological Technology COVID-19 Diagnostic Testing Product
Table 123. Innovita Biological Technology Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 124. Innovita Biological Technology Recent Development
Table 125. Guangzhou Wondfo Biotech Company Details
Table 126. Guangzhou Wondfo Biotech Business Overview
Table 127. Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Product
Table 128. Guangzhou Wondfo Biotech Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 129. Guangzhou Wondfo Biotech Recent Development
Table 130. Guangdong Hecin-Scientific Company Details
Table 131. Guangdong Hecin-Scientific Business Overview
Table 132. Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Product
Table 133. Guangdong Hecin-Scientific Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 134. Guangdong Hecin-Scientific Recent Development
Table 135. Dynamiker Biotechnology (Tianjin) Company Details
Table 136. Dynamiker Biotechnology (Tianjin) Business Overview
Table 137. Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Product
Table 138. Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 139. Dynamiker Biotechnology (Tianjin) Recent Development
Table 140. ADVAITE Company Details
Table 141. ADVAITE Business Overview
Table 142. ADVAITE COVID-19 Diagnostic Testing Product
Table 143. ADVAITE Revenue in COVID-19 Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 144. ADVAITE Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Diagnostic Testing Market Share by Type: 2020 VS 2027
Figure 2. Nucleic Acid Testing Features
Figure 3. Antibody Testing Features
Figure 4. Global COVID-19 Diagnostic Testing Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Scientific Research Case Studies
Figure 7. COVID-19 Diagnostic Testing Report Years Considered
Figure 8. Global COVID-19 Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global COVID-19 Diagnostic Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global COVID-19 Diagnostic Testing Market Share by Regions: 2020 VS 2027
Figure 11. Global COVID-19 Diagnostic Testing Market Share by Regions (2022-2027)
Figure 12. Global COVID-19 Diagnostic Testing Market Share by Players in 2020
Figure 13. Global Top COVID-19 Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COVID-19 Diagnostic Testing as of 2020
Figure 14. The Top 10 and 5 Players Market Share by COVID-19 Diagnostic Testing Revenue in 2020
Figure 15. Global COVID-19 Diagnostic Testing Revenue Market Share by Type (2016-2021)
Figure 16. Global COVID-19 Diagnostic Testing Revenue Market Share by Type (2022-2027)
Figure 17. North America COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America COVID-19 Diagnostic Testing Market Share by Type (2016-2027)
Figure 19. North America COVID-19 Diagnostic Testing Market Share by Application (2016-2027)
Figure 20. North America COVID-19 Diagnostic Testing Market Share by Country (2016-2027)
Figure 21. United States COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe COVID-19 Diagnostic Testing Market Share by Type (2016-2027)
Figure 25. Europe COVID-19 Diagnostic Testing Market Share by Application (2016-2027)
Figure 26. Europe COVID-19 Diagnostic Testing Market Share by Country (2016-2027)
Figure 27. Germany COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific COVID-19 Diagnostic Testing Market Share by Type (2016-2027)
Figure 35. Asia-Pacific COVID-19 Diagnostic Testing Market Share by Application (2016-2027)
Figure 36. Asia-Pacific COVID-19 Diagnostic Testing Market Share by Region (2016-2027)
Figure 37. China COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America COVID-19 Diagnostic Testing Market Share by Type (2016-2027)
Figure 45. Latin America COVID-19 Diagnostic Testing Market Share by Application (2016-2027)
Figure 46. Latin America COVID-19 Diagnostic Testing Market Share by Country (2016-2027)
Figure 47. Mexico COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa COVID-19 Diagnostic Testing Market Share by Type (2016-2027)
Figure 51. Middle East & Africa COVID-19 Diagnostic Testing Market Share by Application (2016-2027)
Figure 52. Middle East & Africa COVID-19 Diagnostic Testing Market Share by Country (2016-2027)
Figure 53. Turkey COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE COVID-19 Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Cellex Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 57. Abbott Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 58. Roche Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 59. BioMedomics Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 60. BD Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 61. Henry Schein Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 62. Safecare Bio-Tech Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 63. Mayo Clinic Laboratories Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 64. Chembio Diagnostics Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 65. Mount Sinai Laboratory Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 66. Ortho Clinical Diagnostics Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 67. Zhejiang Orient Gene Biotech Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 68. Innovita Biological Technology Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 69. Guangzhou Wondfo Biotech Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 70. Guangdong Hecin-Scientific Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 71. Dynamiker Biotechnology (Tianjin) Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 72. ADVAITE Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の新型コロナウイルス感染症血清学検査市場規模・現状・予測（2021年-2027年） Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen by looking at their immune response.These tests can give greater detail into the prevalence of a disease in a population by identifying individuals who have developed antibodie…- 世界のドライブスルー方式新型コロナウイルス感染症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drive-through COVID-19 Testing Market The global Drive-through COVID-19 Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
- 世界の新型コロナウイルス感染症検査市場規模・現状・予測（2021年-2027年） In 2021, the global Covid-19 Testing market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global Covid-19 Testing status, future forecast, growth opportunity, key market, and key players. The…
- 世界の豚診断検査市場規模・現状・予測（2021年-2027年） Swine diagnostic testing is extremely important for pork breeders to keep adverse effects on production and minimum economic losses. Growing consumption of pork meat is expected to be the prime factor driving the growth of global swine diagnostic testing market. Market Analysis and Insights: Global …
- 世界のIVD（体外診断）検査市場規模・現状・予測（2021年-2027年） In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person’s state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. Significant technologies incorp…